Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    16%
  • Revenue 3 Yr Growth Rank
    94
  • EPS 3 Yr Annual Growth Rate
    43%
  • EPS 3 Yr Growth Rank
    43
  • Total Return 3 Yr Annual Rate
    42%
  • Total Return 3 Yr Rank
    19

The N.J. biotech has grown on strong demand for its pharmaceutical ingredients. It has been expanding facilities in the U.S., Italy, and Sweden.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Information

Location
East Rutherford, N.J.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Steven Klosk
Websitehttp://www.cambrex.com
Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.

Revenue, Net Income

Revenue past four quarters ($M)$501
Net Income past four quarters ($M)$87

Growth Rates and Ranks

Revenue 3 Yr Growth Rank94
Revenue 3 Yr Annual Growth Rate16%
EPS 3 Yr Growth Rank43
EPS 3 Yr Annual Growth Rate43%
Total Return 3 Yr Rank19
Total Return 3 Yr Annual Rate42%
Beat S&P 500 (9.6%)
yes
P/E Ratio21